FDA Approves New Restless Legs Syndrome Drug Horizant

The FDA has approved a new drug called Horizant to treat moderate-to-severe restless legs syndrome.

Click here to read the full story.

Post a Comment

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.